Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario Ricardo.

Slides:

Advertisements

Similar presentations

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Advertisements

Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part I: Methods and Power Analysis Douglas F. Levinson, Matthew D. Levinson, Ricardo Segurado,

Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.

Nine Novel Germline Gene Variants in the RET Proto-Oncogene Identified in Twelve Unrelated Cases Syed A. Ahmed, Karen Snow-Bailey, W. Edward Highsmith,

Development of a Novel One-Tube Isothermal Reverse Transcription Thermophilic Helicase-Dependent Amplification Platform for Rapid RNA Detection James Goldmeyer,

Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer Kenji Nakano, Elizabeth Watney,

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.

Quantification of Parvovirus B19 DNA Using COBAS AmpliPrep Automated Sample Preparation and LightCycler Real-Time PCR Stefan Schorling, Gunnar Schalasta,

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Accurate Molecular Characterization of Formalin-Fixed, Paraffin-Embedded Tissues by microRNA Expression Profiling Anna E. Szafranska, Timothy S. Davison,

Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice Edward Balish, Thomas Warner The American Journal of Pathology.

Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival

Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers Rebecca A. Betensky, Catherine.

Vida Kocbek, Katja Vouk, Nick A. Bersinger, Michael D

Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes

In Silico Proficiency Testing for Clinical Next-Generation Sequencing

Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses Narasimhan Nagan, Nicole E. Faulkner,

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Neal I. Lindeman, Philip T. Cagle, Mary.

Diagnostic Application of an Extensive Gene Panel for Leber Congenital Amaurosis with Severe Genetic Heterogeneity Moon-Woo Seong, Soo Hyun Seo, Young.

Cystic Fibrosis The Journal of Molecular Diagnostics

Molecular Genetics of Pediatric Soft Tissue Tumors

Somatic Mutations of PI3K in Early and Advanced Gallbladder Cancer

Mutation Screening in Juvenile Polyposis Syndrome

Joanna Wang, Chetan Bettegowda The Journal of Molecular Diagnostics

Truncating Variants in the Majority of the Cytoplasmic Domain of PCDH15 Are Unlikely to Cause Usher Syndrome 1F Cynthia Perreault-Micale, Alexander Frieden,

Increased Sensitivity of the Roche COBAS AMPLICOR HCV Test, Version 2

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar

Cornelis J. J. Huijsmans, Jeroen Poodt, Paul H. M. Savelkoul, Mirjam H

A Lean Laboratory The Journal of Molecular Diagnostics

Jacquelyn D. Riley, Gary W

CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies

ALK Status Testing in Non–Small Cell Lung Carcinoma

Patrick R. Murray The Journal of Molecular Diagnostics

Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer Daniel Trujillano, Maximilian.

William L. Gerald, M.D., Ph.D, 1954–2008

Genetics: It's Coming to a Clinic Near You

Impact of Rapid Molecular Respiratory Virus Testing on Real-Time Decision Making in a Pediatric Emergency Department Daniel T. Rogan, Mohit S. Kochar,

Kyong-Ah Yoon, Sohee Park, Sang Hee Lee, Jin Hee Kim, Jin Soo Lee

Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next- Generation Sequencing on a Four-Gene Panel Ava Kwong, Vivian Y. Shin,

Pedram Gerami, Susan S. Jewell, Pedram Pouryazdanparast, Jeffery D

The Human Androgen Receptor X-Chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations Michaël Boudewijns, Jacques.

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients Stephen.

BRAF Mutation Testing in Solid Tumors

Skin Biopsy Is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-Linked Alport's Syndrome Fang Wang, Dan Zhao, Jie.

Multiplex Bead Suspension Array for Screening Neisseria gonorrhoeae Antibiotic Resistance Genetic Determinants in Noncultured Clinical Samples Sergey.

The Molecular Pathology of Primary Immunodeficiencies

GeneTests: Integrating Genetic Services into Patient Care*

Genetic Heterogeneity in Saliva from Patients with Oral Squamous Carcinomas Adel K. El-Naggar, Li Mao, Gregg Staerkel, Madelene M. Coombes, Susan L. Tucker,

Vida Kocbek, Katja Vouk, Nick A. Bersinger, Michael D

Anu Aggarwal, Manu Jamwal, Ganesh K

Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients Elena M. Stoffel, Anu Chittenden

Ayalew Tefferi, Pierre Noel, Curtis A. Hanson

Multiple Sequence Variants in Hereditary Hemorrhagic Telangiectasia Cases Jamie McDonald, Friederike Gedge, Allene Burdette, James Carlisle, Changkuoth.

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers Wenhsiang Wen, Wangjuh (Sting) Chen, Nick Xiao, Ryan.

Erratum The American Journal of Human Genetics

Statistical Treatment of Fluorescence in Situ Hybridization Validation Data to Generate Normal Reference Ranges Using Excel Functions Allison L. Ciolino,

Use of Pyrosequencing of 16S rRNA Fragments to Differentiate between Bacteria Responsible for Neonatal Sepsis Jeanne A. Jordan, Allyson R. Butchko, Mary.

Karen Snow-Bailey, Ph.D., 1961–2006

Extra Alleles in FMR1 Triple-Primed PCR

Journal of Investigative Dermatology

Varying Mutational Alterations in Multiple Primary Melanomas

Clinical Experience with the Cervista HPV HR Assay

Immunohistochemistry versus Microsatellite Instability Testing for Screening Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal.

Angiotensin I-Converting Enzyme

BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits

Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

CAT25 Is a Mononucleotide Marker to Identify HNPCC Patients

The History and Impact of Molecular Coding Changes on Coverage and Reimbursement of Molecular Diagnostic Tests Susan J. Hsiao, Mahesh M. Mansukhani,

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario Ricardo dos Santos Vidal, Andrea Hawrysh, Jagdeep S. Walia, Scott Davey, Harriet Feilotter The Journal of Molecular Diagnostics Volume 18, Issue 3, Pages 362-369 (May 2016) DOI: 10.1016/j.jmoldx.2015.11.007 Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Cumulative frequency of Ontario Ministry of Health and Long Term Care established risk criteria assigned to individuals in the Kingston General Hospital patient cohort. The Journal of Molecular Diagnostics 2016 18, 362-369DOI: (10.1016/j.jmoldx.2015.11.007) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Distribution of Ontario Ministry of Health and Long Term Care established risk criteria for the original and reassessed pedigree data with the use of a representative subset of 575 patients. ∗P < 0.05. The Journal of Molecular Diagnostics 2016 18, 362-369DOI: (10.1016/j.jmoldx.2015.11.007) Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions